Sonendo, Inc. (SONX)
1.20
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Sonendo Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | 1.413M |
| September 30, 2024 | 1.588M |
| June 30, 2024 | 1.568M |
| March 31, 2024 | 2.189M |
| December 31, 2023 | 1.765M |
| September 30, 2023 | 2.787M |
| June 30, 2023 | 2.764M |
| March 31, 2023 | 2.927M |
| Date | Value |
|---|---|
| December 31, 2022 | 3.58M |
| September 30, 2022 | 4.061M |
| June 30, 2022 | 3.787M |
| March 31, 2022 | 4.604M |
| December 31, 2021 | 3.941M |
| September 30, 2021 | 4.285M |
| September 30, 2020 | 4.418M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Align Technology, Inc. | 102.03M |
| Dentsply Sirona, Inc. | 45.00M |
| Milestone Scientific, Inc. | 0.0066M |
| Envista Holdings Corp. | 30.40M |
| Abbott Laboratories | 892.00M |